Cephaeline
AlkaPlorer ID: AK004465
Synonym: None
IUPAC Name: (1R)-1-[[(2S,3R,11bS)-3-ethyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-yl]methyl]-7-methoxy-1,2,3,4-tetrahydroisoquinolin-6-ol
Structure
SMILES: CC[C@H]1CN2CCC3=CC(OC)=C(OC)C=C3[C@@H]2C[C@@H]1C[C@H]1NCCC2=CC(O)=C(OC)C=C21
InChI: InChI=1S/C28H38N2O4/c1-5-17-16-30-9-7-19-13-27(33-3)28(34-4)15-22(19)24(30)11-20(17)10-23-21-14-26(32-2)25(31)12-18(21)6-8-29-23/h12-15,17,20,23-24,29,31H,5-11,16H2,1-4H3/t17-,20-,23+,24-/m0/s1
InChIKey: DTGZHCFJNDAHEN-OZEXIGSWSA-N
Reference
Tetrahydroisoquinoline-monoterpene and iridoid glycosides from Alangium lamarckii
PubChem CID: 442195
CAS: 483-17-0
LOTUS: LTS0009460
SuperNatural Ⅲ: SN0074865-03
NPASS: NPC284183
Source
Properties Information
Molecule Weight: 466.6220000000003
TPSA?: 63.19000000000001
MolLogP?: 4.640400000000005
Number of H-Donors: 2
Number of H-Acceptors: 6
RingCount: 5
Activities Information
| Organism | Target Name | Standard Type | Standard Value | Standard Units | doi |
|---|---|---|---|---|---|
| Chlorocebus sabaeus | Vero | IC50 | 5.3 | ug.mL-1 | 10.1021/np030086k |
| Entamoeba histolytica | Entamoeba histolytica | IC50 | 3.26 | ug.mL-1 | 10.1007/s00044-011-9767-1 |
| Homo sapiens | A549 | IC50 | 3000.0 | nM | 10.1021/acs.jnatprod.9b00670 |
| Homo sapiens | BT-549 | IC50 | 0.86 | ug.mL-1 | 10.1021/np030086k |
| Homo sapiens | BXPC-3 | Activity | 0.024 | ug ml-1 | 10.1021/np700738k |
| Homo sapiens | DU-145 | Activity | 0.0098 | ug ml-1 | 10.1021/np700738k |
| Homo sapiens | HeLa | IC50 | 7600.0 | nM | 10.1021/acs.jnatprod.9b00670 |
| Homo sapiens | HL-60 | IC50 | 14.9 | ug.mL-1 | 10.1021/np030086k |
| Homo sapiens | KB | IC50 | 0.33 | ug.mL-1 | 10.1021/np030086k |
| Homo sapiens | KM-20L2 | Activity | 0.022 | ug ml-1 | 10.1021/np700738k |
| Homo sapiens | Leukocyte adhesion glycoprotein LFA-1 alpha | IC50 | 10.0 | ug.mL-1 | 10.1021/np030086k |
| Homo sapiens | Leukocyte adhesion glycoprotein LFA-1 alpha | MIC | 6.9 | ug.mL-1 | 10.1021/np030086k |
| Homo sapiens | NCI-H460 | Activity | 0.022 | ug ml-1 | 10.1021/np700738k |
| Homo sapiens | OVCAR-3 | Activity | 0.032 | ug ml-1 | 10.1021/np700738k |
| Homo sapiens | SF-295 | Activity | 0.018 | ug ml-1 | 10.1021/np700738k |
| Homo sapiens | SK-MEL | IC50 | 0.25 | ug.mL-1 | 10.1021/np030086k |
| Homo sapiens | SK-OV-3 | IC50 | 0.18 | ug.mL-1 | 10.1021/np030086k |
| Homo sapiens | SK-OV-3 | IC50 | 100.0 | nM | 10.1021/acs.jnatprod.9b00670 |
| Leishmania donovani | Leishmania donovani | IC50 | 0.03 | ug.mL-1 | 10.1021/np030086k |
| Leishmania donovani | Leishmania donovani | IC90 | 1.5 | ug.mL-1 | 10.1021/np030086k |
| Mus musculus | P388 | Activity | 0.0027 | ug ml-1 | 10.1021/np700738k |
| Plasmodium falciparum | Plasmodium falciparum | IC50 | 0.0277 | ug.mL-1 | 10.1021/np030086k |
| Plasmodium falciparum | Plasmodium falciparum | IC50 | 0.038 | ug.mL-1 | 10.1021/np030086k |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | IC50 | 19952.62 | nM | 10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | IC50 | 20000.0 | nM | 10.6019/CHEMBL4651402 |
| None | Unchecked | Ratio | 2.17 | None | 10.1021/np030086k |
| None | Unchecked | Ratio IC50 | 132.0 | None | 10.1021/np030086k |
| None | Unchecked | Ratio IC50 | 193.0 | None | 10.1021/np030086k |
